Literature DB >> 22479165

Rhabdomyolysis following a short course of clarythromycin.

Anna M Schor1, Ann Hellerstein.   

Abstract

A healthy 5-year-old girl developed myalgia and an elevated creatine kinase concentration after 4 days of normal doses of clarithromycin. Myalgias resolved and creatine kinase values returned to normal following discontinuation of clarithromycin. No other precipitating factors or interacting drugs were identified; hence, clarithromycin was suspected as the cause of the rhabdomyolysis.

Entities:  

Keywords:  adverse drug event; clarithromycin; pediatric; rhabdomyolysis

Year:  2011        PMID： 22479165      PMCID： PMC3292534          DOI： 10.5863/1551-6776-16.3.216

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


  9 in total

Review 1.  Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.

Authors:  J F Westphal
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 2.  Safety and efficacy of statins in Asians.

Authors:  James K Liao
Journal:  Am J Cardiol       Date:  2006-12-15       Impact factor: 2.778

Review 3.  Rhabdomyolysis and acute kidney injury.

Authors:  Xavier Bosch; Esteban Poch; Josep M Grau
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

4.  Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Authors:  An Wang; Bang-Ning Yu; Chen-Hui Luo; Zhi-Rong Tan; Gan Zhou; Lian-Sheng Wang; Wei Zhang; Zhi Li; Jie Liu; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2005-01-14       Impact factor: 2.953

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Acute pediatric rhabdomyolysis: causes and rates of renal failure.

Authors:  Rebekah Mannix; Mei Lin Tan; Robert Wright; Marc Baskin
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

Review 7.  Rhabdomyolysis: a review of the literature.

Authors:  F Y Khan
Journal:  Neth J Med       Date:  2009-10       Impact factor: 1.422

8.  Rhabdomyolysis following clarithromycin monotherapy.

Authors:  Zachary Z Brener; Ilya Bilik; Boris Khorets; James F Winchester; Michael Bergman
Journal:  Am J Med Sci       Date:  2009-07       Impact factor: 2.378

9.  Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration.

Authors:  Khaled Abduljalil; Martina Kinzig; Jürgen Bulitta; Stefan Horkovics-Kovats; Fritz Sörgel; Michael Rodamer; Uwe Fuhr
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.